SavedAdd your journal

Journals / Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2010 / Cilt: 50 - Sayı: 1

Evaluation of impact of hypertension on neuropathy by clinical and neurophysiological tests

Hipertansiyonun nöropati üzerine etkisinin klinik ve nörofizyolojik testlerle araştırılması

Mehmet SARAÇOĞLU
Hakan TOKU
Ece BOYLU
Pages
29–40
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The differences of the study group and the control group of sural and peroneal sensory amplitudes were statistically significant (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hypertension may play a role in the development of polyneuropathy in patients with unexplained polineuropathy etiology.
📊
Key Findings & Data:To test this hypothesis, we selected our group of 54 subjects (36 hypertensive and 18 controls) among subjects in whom factors that may contribute to neuropathy (like diabetes, renal insufficiency, vitamin B12 insufficiency, hypothyroidism, monoclonal gammapathy, paraneoplastic phenomenon, spinal and hereditary reasons) were ruled out.
💡
Conclusion & Impact:The differences of the study group and the control group of sural and peroneal sensory amplitudes were statistically significant (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hypertension may play a role in the development of polyneuropathy in patients with unexplained polineuropathy etiology. To test this hypothesis, we selected our group of 54 subjects (36 hypertensive and 18 controls) among subjects in whom factors that may contribute to neuropathy (like diabetes, renal insufficiency, vitamin B12 insufficiency, hypothyroidism, monoclonal gammapathy, paraneoplastic phenomenon, spinal and hereditary reasons) were ruled out. After detailed neurological examination, electrophysiological investigations were carried out.As a result of this study, especially the lower extremity sensory amplitudes were found to be significant lower in the study group. The differences of the study group and the control group of sural and peroneal sensory amplitudes were statistically significant (p

Özet

Nedeni ortaya konamayan polinöropatili hastalarda polinöropati gelişiminde hipertansiyonun da rol oynabileceği varsayımını akla gelmektedir. Bu varsayımımızı gösterebilmek amacıyla gerekli biyokimyasal ve görüntüleme yöntemlerinin kullanılması sonucu olası nöropati nedenlerinin (diyabet, böbrek yetmezliği, vitamin B12 yetmezliği, hipotiroidizm, monoklonal gammopati, paraneoplastik fenomen ve herediter nedenler, vb.) dışlandığı aynı yaş aralığında 36 hipertansif ve 18 kontrol grubuna olmak üzere toplam 54 ka- tılımcı aldık. Ayrıntılı nörolojik muayenenin ardından elektrofizyolojik incelemeler yaptık.Otonomik işlevin değerlendirilmesi için arteriyel tansiyonun (TA) yatar, oturur ve ayakta durur pozisyonlarda ölçümü yapıldı ve hastalar her bir pozisyonda bir dakika tutulduktan sonra TA ölçüldü.Çalışma sonucunda hipertansif grupta kontrol grubuna göre özellikle alt ekstremite duyu genlikleri düşük elde edildi. Sural ve peroneal duyu genlikleri istatiksiksel olarak anlamlı derecede belirgin olarak kontrol grubundan düşüktü (p

🔖

Cite This Article

SARAÇOĞLU, M., TOKU, H., BOYLU, E. (2022). Evaluation of impact of hypertension on neuropathy by clinical and neurophysiological tests. Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 50 - Sayı: 1, 29–40. https://ajindex.com/articles/535461

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Adler, A.I., I.M. Stratton, H.A. Neil, et al. 2000. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321: 412–419
  2. Bevilacqua MP, Pober JS, Majeau GR. Interleukin-l (IL-n induces biosynthesis and cell surface expressin of pro-coagulant activity in human vascular endothelial cells. J Exp med. 1984;160:618-623
  3. Cameron NE, Cotter MA, Robertson S. Angiotensin converting enzyme inhibition prevents development of muscle and nevre dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats. Diabetologia 1992; 35: 12–18
  4. Diabetic polyneuropathy in controlled clinical trials: consensus report of the peripheral nerve society. Ann Neurol 1995; 38: 478–82.5. Di Paolo, B., P. Cappelli, C. Spisni, et al. 1982. New electrophysiological assessments for the early diagnosis of encephalopathy and peripheral neuropathy in chronic uraemia. Int. J. Tissue React. 4: 301–307
  5. Dyck PJ, Davies JL, Litchy WJ, O’Brien PC. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study Cohort. Neurology 1997; 49: 229–39
  6. Forrest, K.Y., R.E. Maser, G. Pambianco, Et Al. 1997. Hypertension as a risk factor for diabetic neuropathy: a prospective study. Diabetes 46: 665–670
  7. Franklin, G.M., S.M. Shetterly, J.A. Cohen, et al. 1994. Risk factors for distal symmetric neuropathy in NIDDM. The San Luis Valley diabetes study. Diabetes Care 17: 1172–1177. 9.Gall M-A, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving H-H. Albuminuria and poor glycaemic control predict mortality in NIDDM.Diabetes 1995; 44: 1303–09
  8. Giannini C, Dyck PJ. Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus. Ann Neurol 1994; 36: 408–15
  9. Gonzalez-Clemente, J.M., D. Mauricio, C. Richart, et al. 2005. Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus. Clin. Endo. 63: 525–529
  10. Hallenbeck JM. Inflammatory reactions at the blood-endothelial interface in acute stroke. Adv Neurol. 1996; 71:281-300
  11. Janka HU, Warram JH, Rand LJ, Krolewski AS. Risk factors for the progression of background retinopathy in long standing IDDM. Diabetes 1989; 38: 460–64
  12. Keaney JF. Atherosclerosis: from lsion formation to plaque activation and endothelial dysfunction. Mol Aspects Med. 200;21:99-166 15. Kitazono T, Faraci